Market Cap 🚀13 Apr 2026 09:55
We now have 322,330,221 shares in issues.
At 0.25p this is £805,825 Mcap.
We have continued support and contracts with both J&J and Pfizer.
The directors have put up loans to help bridge the funding gap which they are actively working to solve.
This is a great opportunity to see good multiples from the current value. Funding will be sorted in a non dilutive way (in my opinion)
At 1p the Mcap would be £3.2m
At 4p the Mcap would be £12.9m
Both of these are still very small in the long run for the product and connections to major pharmaceutical companies.
DYOR
Good luck holders.